Вестник Ассоциации пульмонологов Центральной Азии 14-том 9-нөмір (2025) · 216-224-беттер

HEPATITIS «C» AND «B» CO-INFECTION: IMPACT ON TREATMENT OUTCOMES IN MDR-TB PATIENTS

Mamatov L.B., Abdugapparov F.B., Eshmuradov X.I.

Дереккөзден оқу PDF

Аңдатпа

Dual infections of multidrug-resistant tuberculosis (MDR-TB) or rifampicin-resistant tuberculosis (RR-TB) and hepatitis C virus (HCV) have resulted in nearly half a million cases of MDR-TB annually worldwide and 71 million people living with HCV. Aim of the study to analyze the features of the course of MDR-TB when combined with viral hepatitis “C” and “B”. We examined 354 MDR-TB patients aged from 20 to 70 years who were undergoing inpatient treatment in the 2-therapeutic department of the Tashkent City Clinical Hospital of Phthisiology and Pulmonology (TCCHPhP) in the city of Tashkent in 2021-2023. It was found that out of 354 patients, 86 (24.3%) were diagnosed with viral hepatitis. Accordingly, the development included 86 patients with co-infection with MDR-TB and viral hepatitis. Of these, 21 (24.4%) were newly diagnosed patients, 65 (75.6%) were previously treated. The spectrum of viral hepatitis was as follows: 75 patients had viral hepatitis C (87.2%), 5 patients had a combination of viral hepatitis “C” and “B” (5.8%) and 6 had viral hepatitis “B” (7%). Among those examined, the social characteristics of the patients played an important role. Thus, the bulk were unemployed—77 (89.5%). Workers and employees account for only 9 (10.5 %) people. 53 people had a criminal record, which accounted for 61.6% of patients. Persons without a fixed place of residence made up 17 (19.7%) patients. Almost all patients had secondary education - 77 (89.5%), 9 (10.5%) patients had higher education. All patients had bad habits: smoking was noted in 60 (69.7%) patients, alcohol abuse - in 52 (60.4%), injecting drugs - 16 (18.6%) and nasvay use - in 6 (6.9%). Moreover, more than half of the patients had two or three bad habits - 49 (56.9%). In conclusion the study of medical and social characteristics made it possible to establish that patients with MDR/RR tuberculosis in combination with viral hepatitis belong in most cases to a socially maladjusted contingent (76.2%). The presence of bad habits, and in more than half of the cases two or three, as well as the presence of a criminal record (61.6%), persons without a fixed place of residence (19.7 %), alcohol abuse (60.4%), injection drugs use (18.6%) significantly affects the treatment process.

MDR-TB, viral hepatitis “C” and “B”, TB treatment outcome

Метадеректер дереккөзі: журналдың OAI-PMH архиві · Sindex толық мәтінді сақтамайды, дереккөзге сілтеме береді.

Дәйексөз алу

APA 7
Mamatov L.B., Abdugapparov F.B. & Eshmuradov X.I. (2025). HEPATITIS «C» AND «B» CO-INFECTION: IMPACT ON TREATMENT OUTCOMES IN MDR-TB PATIENTS. Вестник Ассоциации пульмонологов Центральной Азии, 14(9), 216-224.
GOST R 7.0.5
Mamatov L.B., Abdugapparov F.B., Eshmuradov X.I. HEPATITIS «C» AND «B» CO-INFECTION: IMPACT ON TREATMENT OUTCOMES IN MDR-TB PATIENTS // Вестник Ассоциации пульмонологов Центральной Азии. 2025. Т. 14. № 9. С. 216-224.
BibTeX
@article{f.b.2025,
  author  = {Mamatov L.B., Abdugapparov F.B. and Eshmuradov X.I.},
  title   = {HEPATITIS «C» AND «B» CO-INFECTION: IMPACT ON TREATMENT OUTCOMES IN MDR-TB PATIENTS},
  journal = {Вестник Ассоциации пульмонологов Центральной Азии},
  year    = {2025},
  volume  = {14},
  number  = {9},
  pages   = {216-224}
}
RIS
TY  - JOUR
AU  - Mamatov L.B., Abdugapparov F.B.
AU  - Eshmuradov X.I.
TI  - HEPATITIS «C» AND «B» CO-INFECTION: IMPACT ON TREATMENT OUTCOMES IN MDR-TB PATIENTS
JO  - Вестник Ассоциации пульмонологов Центральной Азии
PY  - 2025
VL  - 14
IS  - 9
SP  - 216
EP  - 224
ER  -